O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020308232 |
_version_ | 1818598944217759744 |
---|---|
author | P. Pannus P. Adams E. Willems L. Heyndrickx M. Van Frankenhuijsen E. Florence M. Kiselinova S. Rutsaert K. Vervisch W. Despiegelaere C. Devaux L. Vandekerckhove G. Vanham |
author_facet | P. Pannus P. Adams E. Willems L. Heyndrickx M. Van Frankenhuijsen E. Florence M. Kiselinova S. Rutsaert K. Vervisch W. Despiegelaere C. Devaux L. Vandekerckhove G. Vanham |
author_sort | P. Pannus |
collection | DOAJ |
first_indexed | 2024-12-16T12:11:44Z |
format | Article |
id | doaj.art-21a27becc15c453ea5a370d771f7777e |
institution | Directory Open Access Journal |
issn | 2055-6640 |
language | English |
last_indexed | 2024-12-16T12:11:44Z |
publishDate | 2017-09-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Virus Eradication |
spelling | doaj.art-21a27becc15c453ea5a370d771f7777e2022-12-21T22:32:10ZengElsevierJournal of Virus Eradication2055-66402017-09-0133O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?P. Pannus0P. Adams1E. Willems2L. Heyndrickx3M. Van Frankenhuijsen4E. Florence5M. Kiselinova6S. Rutsaert7K. Vervisch8W. Despiegelaere9C. Devaux10L. Vandekerckhove11G. Vanham12Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, Belgiumhttp://www.sciencedirect.com/science/article/pii/S2055664020308232 |
spellingShingle | P. Pannus P. Adams E. Willems L. Heyndrickx M. Van Frankenhuijsen E. Florence M. Kiselinova S. Rutsaert K. Vervisch W. Despiegelaere C. Devaux L. Vandekerckhove G. Vanham O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? Journal of Virus Eradication |
title | O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? |
title_full | O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? |
title_fullStr | O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? |
title_full_unstemmed | O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? |
title_short | O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? |
title_sort | o7 does viral suppressive capacity in cart treated hiv infected patients correlate with disease parameters viral reservoir measures or cytotoxic t cell phenotype |
url | http://www.sciencedirect.com/science/article/pii/S2055664020308232 |
work_keys_str_mv | AT ppannus o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT padams o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT ewillems o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT lheyndrickx o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT mvanfrankenhuijsen o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT eflorence o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT mkiselinova o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT srutsaert o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT kvervisch o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT wdespiegelaere o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT cdevaux o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT lvandekerckhove o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype AT gvanham o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype |